Stereotaxis (STXS) Stock Climbs After Major European Approval
When Stereotaxis, Inc. (NYSE: STXS) revealed that its ground-breaking MAGiC ablation catheter had received European CE Mark clearance, STXS shares saw a sharp increase. The stock price increased 14.61% to $2.51 as of the most recent report. A Breakthrough in Robotic Electrophysiology For Stereotaxis and the larger community of medical professionals at the forefront of …
Stereotaxis (STXS) Stock Climbs After Major European Approval Read More »